Literature DB >> 21566789

The relationship of opium addiction with coronary artery disease.

Mohammad Masoomi1, Mohammad Arash Ramezani, Hadi Karimzadeh.   

Abstract

OBJECTIVES: There is some controversy regarding the effect of opium addiction on the coronary artery disease (CAD). The aim of this study was to determine the association between chronic opium consumption and CAD.
METHODS: This study had a case-control design. The patients recruited to the study were selected from angiography files in Department of Cardiology in Kerman University of Medical Sciences, Kerman, Iran. The comparison was done between CAD patients and normal subjects. Opium addiction was diagnosed by patient self-report and confirmed with interview based on DSM-IV criteria. Odds ratio with 95% confidence interval were estimated by unconditional logistic regression.
RESULTS: The risk factor of CAD was the same in the two study groups. The significant difference in opium consumption was demonstrated between CAD patients and normal coronary artery subjects (OR=3.8, 95%CI=1.5-9.5). Because of the strong association between cigarette smoking and opium addiction, analysis was done in smoker and non-smoker groups separately. Logistic regression showed opium addiction was the independent risk factor for CAD in non-smokers after adjusting to other CAD risk factors (OR=38, 95%CI=2.7-531.7), but in cigarette smokers opium was not a significant risk factor (OR=13.2, 95%CI=0.85-206.5).
CONCLUSIONS: We confirmed that the opium was an independent risk factor for CAD. Health managers and policy makers should try to aware general population and prepare many preventive programs against substance abuse.

Entities:  

Keywords:  Angiography; Coronary artery disease; Opium; Risk factor

Year:  2010        PMID: 21566789      PMCID: PMC3075529     

Source DB:  PubMed          Journal:  Int J Prev Med        ISSN: 2008-7802


INTRODUCTION

Primary investigation on morphine and its derivatives had been focused on central nervous system (CNS), thoroughly. It has been determined that opioids have many effects on different physiological systems. In recent years, there are a great deal of interest on cardiovascular system because of the cardioprotective role of opioid endogenous and exogenous compounds on ischemic preconditioning (IPC).1 Opioids influence three kinds of receptors in myocytes named mu (μ), kappa (κ) and delta (δ).12 It seems the cardioprotection in ischemic preconditioning is related to (κ) and (δ) receptors.34. Opioids cause IPC and attenuate ischemic reperfusion injury and decrease apoptosis in myocytes, thus infarct size is smaller and ventricular function ameliorates.5 On the other hand, we confront to substance abuse phenomenon. In a 20-year prospective study, the most common cause of death in opioid addicts was coronary artery disease (CAD) diseases (CAD), except accidental events. Furthermore, standardized mortality ratios for CAD has been higher in opioid addicts compared to general population.6 Opium abuse is a major predicament in many countries particularly in the Middle East region. In Iran, the opium addiction is predominant and its prevalence estimated over 3% in general population.78 The most frequent consumption method is inhalation.9 Although opioids have the protective effects on heart and play an important treatment role during ischemic event, the chronic usage of opioid may complicate influence of opioids2, particularly when the consumption ways are different like inhalation. Now, the important question is as follows: what is the effect of opium addiction on CAD? The previous investigation from our center revealed that the opium addiction didn’t correlate to myocardial infarction (MI).10 Another report from Iran determined that the opium addiction was a significant risk factor for CAD (OR=1.8, 95%CI=1.1-3.1).11 In contrast, Marmor and colleagues reported that CAD prevalence in methadone or opioid addict decedents was less than that in non-addict ones and even opioid addiction had a protective effect on CAD (OR=0.43, 95%CI= 0.20 to 0.94).12 This dilemma motivated us to investigate the association of opium addiction and CAD. The aim of this study was to determine the association between opium addiction and CAD by a different design.

MATERIALS AND METHODS

Setting

The study was conducted in Department of Cardiology and Angiography in Shafa Medical Center, one of the biggest hospitals of Kerman University of Medical Sciences. The angiography ward is the only cath lab in Kerman province. We carried out a cohort study of chest pain in our department since February 1st 2007. It included 137 cases till February 1st 2008. The nested case-control study was designed in the cohort study. We recruited the patients who were catheterized. Those cases with positive findings in catheterization were selected as case group and subjects with normal angiography were included in the control group. The research proposal was approved by both research and medical ethics committees in Kerman University of Medical Sciences.

Data collection

Demographic and cardiovascular risk factor information (including hypertension, hyperlipidemia, diabetes mellitus, family history of CAD and smoking) and angiographic data were collected by reviewing the patients’ records. Besides, opium addiction was diagnosed by patient self-report and confirmed with interview based on DSM-IV criteria. Type of substance abuse, duration of abuse and kind of consumption were recorded in interview. All data were registered in structured data collection forms.

Statistical analysis

Data was compared between the two CAD positive and negative groups. The chi-square test was used for analysis of nominal variables. The mean was compared with t test and when it was ranked, the Mann-Whitney test was appropriated. Odds ratio and confidence interval was calculated for every risk factor and tested with Mantel-Haenszel test. The roles of established CAD risk factors as effect modifiers or confounders were evaluated by stratification and were finally considered in the logistic regression models. The analyses were performed by using the SPSS release for Windows, Version 15 (SPSS Inc., Chicago, IL). The P<0.05 was considered significant.

RESULTS

Of 137 cases in our cohort, 91 patients were catheterized and recruited. CAD was delineated in 58 (63.7%) patients; 33 (36.3%) had normal angiography.Table 1shows the demographic characteristics in the two groups. As shown in theTable 1, there were any significant differences in demographic and risk factors between the two study groups. The frequency of opium addiction was 3.8 folds greater in CAD patients and the difference was significant. The significant difference in opium consumption was shown in Figure 1.
Table 1

The frequency of demographic variables and risk factors in the two study groups.

VariablesCVD+CVD-P value
Sex
 Male47220.136*
 Female1111
Age (mean ± SD)57 ± 3.457.1 ± 3.10.848
Hypertension
 Positive1780.635*
 Negative4125
Diabetes
 Positive1260.99*
 Negative4627
Hyperlipidemia
 Positive1990.643*
 Negative3924
Family history
 Positive2690.12*
 Negative3224
Smoking
 Positive24120.663*
 Negative3421

*Fisher’s exact test

independent sample t-test

Figure 1

The comparison of opium addiction between the cardiovascular disease patients and normal groups.

The frequency of demographic variables and risk factors in the two study groups. *Fisher’s exact test independent sample t-test The comparison of opium addiction between the cardiovascular disease patients and normal groups. The risk factors and demographic characteristics were the same in addicted CAD patients and those with normal coronary artery (Table 2). The method of consumption and duration of abuse demonstrated no differences between CAD and normal cases. Additionally, in CAD cases the angiographic characteristics like number of vessels suffering from atherosclerosis, severity of obstruction and ejection fraction didn’t differ between addicted and non-addicted patients. Notably, the strong association between cigarette smoking and opium consumption not only existed in CAD patients, also was observed in healthy subjects (Table 3). Just as coming from tables 1, 2 and 3, the conventional risk factors of CAD correlated neither dependent nor independent variables. However, we modified the effect of cigarette smoking by stratification and multiple logistic regression analysis adjusted the effect of opium addiction by the other risk factors. As shown in table 4, opium abuse was independent risk factor for CAD in non-cigarette smoking cases (OR=38, 95%CI=2.7-531.7), but in cigarette smokers, opium was not a significant risk factor (OR=13.2, 95%CI=0.85-206.5).
Table 2

The frequency of risk factors in opium addicted patients.

VariablesCVD+CVD−P value*
Hypertension
 Positive510.99
 Negative298
Diabetes
 Positive400.752
 Negative309
Hyperlipidemia
 Positive1320.458
 Negative217
Family history
 Positive1710.06
 Negative178
Smoking
 Positive240.666
 Negative2220

*Fisher’s exact test

Table 3

Association between cigarette smoking and opium usage in the two groups under study.

CVD+CVD−
Opium+Opium−Opium+Opium−
Smoking+22284
Smoking−1222120
OR=20.2, 95%CI=4−100.9OR=40, 95%CI=3.8−415
Table 4

Crude and adjusted odds ratio of CVD risk factors separated by cigarette smoking.

CS+CS−
Crude OR (95%CI)Adjusted OR (95%CI)Crude OR (95%CI)Adjusted OR (95%CI)
Opium5.5 (0.8−36)13.2 (0.8−206.5)10.9 (1.3−91.6)38 (2.7−531.7)
Hypertension1 (0.3−3.1)2 (0.5−8.6)
Diabetes mellitus1 (0.15−6.4)3 (0.2−42.8)1.3 (0.34−5)4.2 (0.7−24.9)
Hyperlipidemia9.3 (1.03−84)19.9 (0.9−442.9)0.5 (0.15−1.6)0.1 (0.02−0.9)
Family history2.5 (0.5−11.8)1.8 (0.25−12.8)2 (0.6−6.3)1.7 (0.4−6.6)

CS = cigarette smoking

The frequency of risk factors in opium addicted patients. *Fisher’s exact test Association between cigarette smoking and opium usage in the two groups under study. Crude and adjusted odds ratio of CVD risk factors separated by cigarette smoking. CS = cigarette smoking

DISCUSSION

The results of current study revealed that the frequency of opium addiction in CAD patients was greater than that in normal ones (58.6% vs. 27.3%). However, after adjusting with other risk factors and stratifying based on cigarette smoking because of the great association between opium addiction and cigarette smoking, logistic regression model determined that in non-smokers opium addiction was the independent risk factor for CAD with OR=38 (95%CI=2.7-531.7). In contrast, although the OR was equal to 13.2 in smokers, the difference was not significant (95%CI=0.85-206.5). The opium addiction in our country, Iran, is a very dramatic public health problem. On the other hands, the mortality and morbidity due to CAD is located on the top of the mortality and morbidity list in Iran; many investigators attempt to find the association between opium, CAD and atherosclerosis phenomenon. Previous studies have shown that the range of opium addiction is varied from 10% in coronary artery bypass graft patients13 to 20% in patients with MI.14 One report from our center showed that the opium addiction was not a risk factor in MI patients.10 Sadeghian and colleagues excluded the cigarette smokers from their study and similar to our findings, the opium addiction was the independent risk factor for CAD (OR=1.8, 95%CI=1.1-3.1). They obtained information from angiographic records, retrospectively.11 The other study carried out in patients with cerebrovascular accidents declared the association of opium addiction and cerebrovascular stroke.15 Marmor and colleagues assessed the coronary arteries in decedents who exposed long-term to opiate. They found the opiate dependency was the protective factor for CAD (OR=0.43, 95%CI=0.2-0.94).12 While there is a clinical doubt regarding the relationship of opium addiction and CAD, the physiopharmacologic studies support the effect of opioid on cardiovascular system. Chronic consumption of opioid some effects on heart like release of endogenous substances like P, calcitonin genrelated peptide, adenosine and superactivate adenosine sensitivity and adenylyl cyclase that have the protective effect on cardiac function.2 However, the effect of opioid depends on the receptor subtype activation. For example, Aitchison et al. determined that the excitation of κ receptors deteriorates myocardial perfusion and increases the infarct size dramatically.16 Coles and colleagues reported that blockade of the κ opioid receptors abrogated reperfusion arrhythmias.17 It is interesting that morphine and its derivatives administration during cardiovascular events not only is not harmful also satisfies the patient and the cardiologist. However, chronic consumption of opiates as abuser may be an independent risk factor for CAD. The controversy exists in different studies due to some reasons. For example, opium abuse decreased the serum lipid level.18 But, the new risk factors of CAD vary in opium addicts. Glycosylated hemoglobin, lipoprotein A, C reactive protein, apo B, liver enzymes (ALT, AST) were significantly higher in addicts than in non-addicts; and apo A was lower contrarily.19 Additionally, method of opium consumption influences the lipid and the aforementioned new cardiovascular risk factors, in such a manner that morphine concentration was significantly higher in oral administration.19 A few people in Iran believe the protective effects of opium on cardiovascular disease or diabetes.20 As we demonstrated, opium is an independent CAD risk factor, thus public health manger and policy makers should plan many programs to elevate the knowledge, and finally, change the attitude and practice of general population regarding the opium consumption and its disadvantages. We had some limitations in our study. The best epidemiologic study to fit for the aim of current study was cohort and our design was case-control. However, it was a nested case-control in the cohort study and could confirm the association between opium addiction and CAD. Another limitation in our study was detection of addiction. We used verbal autopsy by aid of DSM-IV criteria and were not able to confirm the addiction by lab test. We endeavored to be accurate as much as possible.
  12 in total

Review 1.  Opioids and cardioprotection.

Authors:  J E Schultz; G J Gross
Journal:  Pharmacol Ther       Date:  2001-02       Impact factor: 12.310

Review 2.  Opioid-induced preconditioning: recent advances and future perspectives.

Authors:  Jason N Peart; Eric R Gross; Garrett J Gross
Journal:  Vascul Pharmacol       Date:  2005-03-17       Impact factor: 5.773

3.  Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning.

Authors:  K A Aitchison; G F Baxter; M M Awan; R M Smith; D M Yellon; L H Opie
Journal:  Basic Res Cardiol       Date:  2000-02       Impact factor: 17.165

4.  The association of opium with coronary artery disease.

Authors:  Saeed Sadeghian; Soodabeh Darvish; Gholamreza Davoodi; Mojtaba Salarifar; Mehran Mahmoodian; Nader Fallah; Abbas Ali Karimi
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-10

5.  Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus.

Authors:  Gholamreza Asadi Karam; Mostafa Reisi; Ali Alizadeh Kaseb; Mohammad Khaksari; Abbas Mohammadi; Mehdi Mahmoodi
Journal:  Addict Biol       Date:  2004-03       Impact factor: 4.280

6.  Mechanisms of opioid delta (delta) and kappa ( kappa) receptors' cardioprotection in ischaemic preconditioning in a rat model of myocardial infarction.

Authors:  A Valtchanova-Matchouganska; J A O Ojewole
Journal:  Cardiovasc J S Afr       Date:  2003 Mar-Apr

7.  Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor.

Authors:  Shinji Okubo; Yujirou Tanabe; Kenji Takeda; Michihiko Kitayama; Seiyu Kanemitsu; Rakesh C Kukreja; Noboru Takekoshi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-01       Impact factor: 4.733

8.  Relative contribution of endogenous opioids to myocardial ischemic tolerance.

Authors:  Matthew A Romano; Elisabeth M Seymour; Jennifer A Berry; Robert A McNish; Steven F Bolling
Journal:  J Surg Res       Date:  2004-05-01       Impact factor: 2.192

9.  Role of kappa-opioid receptor activation in pharmacological preconditioning of swine.

Authors:  James A Coles; Daniel C Sigg; Paul A Iaizzo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-01-23       Impact factor: 4.733

10.  Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter?

Authors:  Sedigheh Asgary; Nizal Sarrafzadegan; Gholam-Ali Naderi; Reza Rozbehani
Journal:  Lipids Health Dis       Date:  2008-11-03       Impact factor: 3.876

View more
  29 in total

Review 1.  Effects of opium consumption on cardiometabolic diseases.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Mark J Eisenberg
Journal:  Nat Rev Cardiol       Date:  2013-10-22       Impact factor: 32.419

2.  Opium Addiction and Correlation with Early and Six-month Outcomes of Presenting with ST Elevation Myocardial Infarction Treated Initially with Thrombolytic Therapy.

Authors:  Mehdi Mousavi; Solmaz Kalhor; Mahlaa Alizadeh; Mohamad Reza Movahed
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

3.  Opium use and risk of mortality from digestive diseases: a prospective cohort study.

Authors:  Masoud M Malekzadeh; Hooman Khademi; Akram Pourshams; Arash Etemadi; Hossein Poustchi; Mohammad Bagheri; Masoud Khoshnia; Amir Ali Sohrabpour; Ali Aliasgari; Elham Jafari; Farhad Islami; Shahryar Semnani; Christian C Abnet; Paul D P Pharoah; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Reza Malekzadeh; Farin Kamangar
Journal:  Am J Gastroenterol       Date:  2013-10-22       Impact factor: 10.864

4.  Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran.

Authors:  Hooman Khademi; Reza Malekzadeh; Akram Pourshams; Elham Jafari; Rasool Salahi; Shahryar Semnani; Behrooz Abaie; Farhad Islami; Siavosh Nasseri-Moghaddam; Arash Etemadi; Graham Byrnes; Christian C Abnet; Sanford M Dawsey; Nicholas E Day; Paul D Pharoah; Paolo Boffetta; Paul Brennan; Farin Kamangar
Journal:  BMJ       Date:  2012-04-17

5.  Opium consumption and mid-term outcome of percutaneous coronary intervention in men.

Authors:  Ahmad Sharafi; Hamid Reza Pour Hosseini; Arash Jalali; Mojtaba Salarifar; Ebrahim Nematipour; Mohsen Shojanasab; Hassan Aghajani; Alireza Amirzadegan; Younes Nozari; Mohamad Alidoosti; Alimohammad Haji Zeinali; Seyed Ebrahim Kassaian
Journal:  J Tehran Heart Cent       Date:  2014-07-03

6.  Effects of opium consumption on coronary artery disease risk factors and oral health: Results of Kerman Coronary Artery Disease Risk factors Study a population-based survey on 5900 subjects aged 15-75 years.

Authors:  Hamid Najafipour; Mohammad Masoomi; Armita Shahesmaeili; Ali Akbar Haghdoost; Mahdi Afshari; Hamid Reza Nasri; Masoomeh Kahnooji; Sadra Samadi; Ali Mirzazadeh
Journal:  Int J Prev Med       Date:  2015-05-20

7.  Serum level of plasminogen activator inhibitor type-1 in addicted patients with coronary artery disease.

Authors:  Afsaneh Forood; Reza Malekpour-Afshar; Amin Mahdavi
Journal:  Addict Health       Date:  2014 Summer-Autumn

8.  Relation of opium addiction with the severity and extension of myocardial infarction and its related mortality.

Authors:  Farnaz Dehghani; Mohammad Masoomi; Ali Akbar Haghdoost
Journal:  Addict Health       Date:  2013 Winter-Spring

9.  Studying prevalence and pattern of taking narcotic and ecstasy drugs by patients admitted to special care centers of shahid bahonar hospital, kerman, iran.

Authors:  Mehdi Ahmadi-Nejad; Fatemeh Jadidi; Mahmoud Reza Dehghani; Kouros Divsalar
Journal:  Addict Health       Date:  2012 Winter-Spring

10.  Frequency of Opium Addiction in Patients with Ischemic Stroke and Comparing their Cerebrovascular Doppler Ultrasound Changes to Non-Addicts.

Authors:  Akbar Hamzei-Moghaddam; Mohammad Ali Shafa; Narges Khanjani; Reza Farahat
Journal:  Addict Health       Date:  2013 Summer-Autumn
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.